66 results
Page 3 of 4
6-K
EX-99.1
ua3xzwjt uf
20 Dec 19
Gilead submits new drug application to U.S. Food and Drug Administration under priority review for filgotinib for rheumatoid arthritis treatment
6:01am
6-K
EX-99.1
4n4891 qv9
12 Nov 19
Current report (foreign)
6:15am
6-K
EX-99.2
izk579fm q9efb5hxfe2
25 Oct 19
Solid third quarter 2019 performance with strong balance sheet for continued R&D growth
5:00pm
6-K
EX-99.1
fe9 2757zvi3kd6uw4
11 Oct 19
Gilead and Galapagos Announce Efficacy and Safety Results of Filgotinib Through 52 Weeks In Finch 1 and Finch 3 Studies In Rheumatoid Arthritis
6:00am
6-K
EX-99.1
h99bd7 qoz
5 Sep 19
European Medicines Agency Validates Marketing Application for Filgotinib for the Treatment of Rheumatoid Arthritis
5:24pm
6-K
EX-99.4
bdert l563v
29 Aug 19
Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration
4:44pm
6-K
EX-99.2
n3ptozcspvksh
29 Aug 19
Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration
4:44pm
6-K
EX-99.3
j5f2 eqdlxl15k
29 Aug 19
Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration
4:44pm
6-K
EX-99
s0g8ijkmgyxdwt rm5xl
25 Jul 19
Strong clinical progress in H1, and transformative collaboration with Gilead announced
4:24pm
6-K
EX-99.1
g2otq8w7jf4ff9yy
31 May 19
Current report (foreign)
10:27am
6-K
EX-99.2
venvn5
26 Apr 19
Galapagos reports on historic first quarter 2019
4:06pm
6-K
EX-99.1
ub49di cfsciu
29 Mar 19
Current report (foreign)
6:16am
6-K
EX-99.1
b0nijdmjnjxk0dqde6fs
29 Mar 19
Current report (foreign)
6:02am
6-K
EX-99.1
f82zr9msijl68icl4
29 Mar 19
Current report (foreign)
6:00am
6-K
EX-99.2
p3chn8mocszl7owozzg8
26 Oct 18
Hallmark third quarter 2018 and Annual R&D Update at Galapagos
4:19pm
6-K
EX-99.1
dewoezz
23 Oct 18
Positive Trial Results with Filgotinib In Psoriatic Arthritis and Ankylosing Spondylitis Both Published In the Lancet
7:59am
6-K
EX-99.1
mwmjisd7
22 Oct 18
Phase 3 Data on Filgotinib In Biologic-experienced Rheumatoid Arthritis to Be Presented at 2018 Acr/arhp Annual Meeting
6:05am
6-K
EX-99.1
dtyf 6ag9ib17tzl4
11 Sep 18
Gilead and Galapagos Announce Filgotinib Meets Primary and All Key Secondary Endpoints In First Phase 3 Study In Rheumatoid Arthritis
12:00am